82 related articles for article (PubMed ID: 32855027)
1. [Radiation-induced lymphopenia: Lymphocytes as a new organ at risk].
Laurent PA; Deutsch É
Cancer Radiother; 2023 Sep; 27(6-7):511-518. PubMed ID: 37661506
[TBL] [Abstract][Full Text] [Related]
2. Prevention and treatment of radiotherapy-induced side effects.
Barazzuol L; Coppes RP; van Luijk P
Mol Oncol; 2020 Jul; 14(7):1538-1554. PubMed ID: 32521079
[TBL] [Abstract][Full Text] [Related]
3. [Éditorial. La radiothérapie dix ans après].
Coucke P
Rev Med Liege; 2024 May; 79(S1):1-3. PubMed ID: 38778641
[TBL] [Abstract][Full Text] [Related]
4. Chromosomal radiosensitivity in oncological and non-oncological patients with rheumatoid arthritis and connective tissue diseases.
Rzepka D; Schenker H; Geinitz H; Silberberger E; Kaudewitz D; Schuster B; Kuhlmann L; Schonath M; Ayala Gaona H; Aschacher B; Fietkau R; Schett G; Distel L
Radiat Oncol; 2023 Jun; 18(1):98. PubMed ID: 37287050
[TBL] [Abstract][Full Text] [Related]
5. Correlation Between Serum and Urine Biomarkers and the Intensity of Acute Radiation Cystitis in Patients Treated With Radiation Therapy for Localized Prostate Cancer: Protocol for the Radiotoxicity Bladder Biomarkers (RABBIO) Study.
Helissey C; Cavallero S; Mondot S; Parnot C; Yssaad H; Becherirat S; Guitard N; Thery H; Schernberg A; Breitwiller H; Chargari C; Francois S
JMIR Res Protoc; 2023 Jan; 12():e38362. PubMed ID: 36626198
[TBL] [Abstract][Full Text] [Related]
6. COVID-19-Associated Pneumonia: Radiobiological Insights.
François S; Helissey C; Cavallero S; Drouet M; Libert N; Cosset JM; Deutsch E; Meziani L; Chargari C
Front Pharmacol; 2021; 12():640040. PubMed ID: 34113249
[TBL] [Abstract][Full Text] [Related]
7. Chronic Inflammation and Radiation-Induced Cystitis: Molecular Background and Therapeutic Perspectives.
Helissey C; Cavallero S; Brossard C; Dusaud M; Chargari C; François S
Cells; 2020 Dec; 10(1):. PubMed ID: 33374374
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of radiation-induced late effects: What's new?].
Chargari C; Supiot S; Hennequin C; Chapel A; Simon JM
Cancer Radiother; 2020 Oct; 24(6-7):602-611. PubMed ID: 32855027
[TBL] [Abstract][Full Text] [Related]
9. [Intrinsic radiosensitivity: predictive assays that will change daily practice].
Lacombe J; Riou O; Solassol J; Mangé A; Bourgier C; Fenoglietto P; Pèlegrin A; Ozsahin M; Azria D
Cancer Radiother; 2013 Oct; 17(5-6):337-43. PubMed ID: 23999252
[TBL] [Abstract][Full Text] [Related]
10. Gene therapy and cell therapy for the management of radiation damages to healthy tissues: Rationale and early results.
Khalifa J; François S; Rancoule C; Riccobono D; Magné N; Drouet M; Chargari C
Cancer Radiother; 2019 Sep; 23(5):449-465. PubMed ID: 31400956
[TBL] [Abstract][Full Text] [Related]
11. [Medical prevention and treatment of radiation-induced urological and nephrological complications].
Rehailia-Blanchard A; He MY; Rancoule C; Guillaume É; Guy JB; Vial N; Nivet A; Orliac H; Chargari C; Magné N
Cancer Radiother; 2019 Apr; 23(2):151-160. PubMed ID: 30898418
[TBL] [Abstract][Full Text] [Related]
12. T lymphocytes to predict radiation-induced late effects in normal tissues.
Brengues M; Lapierre A; Bourgier C; Pèlegrin A; Özsahin M; Azria D
Expert Rev Mol Diagn; 2017 Feb; 17(2):119-127. PubMed ID: 27936985
[TBL] [Abstract][Full Text] [Related]
13. [Individual modification of the dose, volume and fractionation of breast radiotherapy].
Bourgier C; Lemanski C; Draghici R; Castan F; Fenoglietto P; Bons F; Farcy-Jacquet MP; Brengues M; Gourgou S; Ozsahin M; Azria D
Cancer Radiother; 2019 Oct; 23(6-7):778-783. PubMed ID: 31378461
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
